(redirected from Betapace)
Also found in: Medical.
Related to Betapace: Betapace AF, Tobramycin sulfate


 (sō′tə-lôl′, -lōl′)
A beta-blocker drug, C12H20N2O3S, used in its hydrochloride form to treat certain cardiac arrhythmias.

[Alteration of sorta (because sotalol is only "sort of" a beta-blocker, since it also has antiarrhythmic effects related to the cellular transport of potassium ions) + (proprano)lol.]


n sotalol m
References in periodicals archive ?
Sotalol hydrochloride is the active ingredient in Betapace AF, a treatment for irregular heart rhythms made by Schering AG unit Berlex Inc.
Other launches during 2004 include seven strengths of Amphetamines Mixed Salts tablets (reference: Adderall tablets, Shire Pharmaceuticals Group), Sotalol AF tablets (reference: Betapace AF tablets, Berlex Laboratories), Phentermine 37.
Berlex Laboratories, which markets the drug as Betapace, filed a supplemental application for approval of this indication.
Drug treatments include Cordarone (amiodarone), Corvert (ibutilide), Tambocor (flecainide), Rythmol (propafenone), Cardioquine (quinidine), Betapace (sotalol) and Tikosyn (dofetilide).
The drug is presently available only in a twice daily formulation as Betapace(R) and Betapace AF(TM) (Berlex) as well as generics.